When does Akzo Nobel report earnings and how does it affect AKZA.AS stock?

Akzo Nobel reports Q4 results on 03 Feb 2026. Earnings can move AKZA.AS stock significantly if revenue, margins, or guidance miss or beat expectations. Watch EPS versus trailing **€0.33** and management commentary on pricing and raw-material costs.

What is Meyka AI's view on AKZA.AS stock valuation?

Meyka AI assigns AKZA.AS a score **69.80** (Grade B, HOLD). Valuation is rich with a PE **179.52**, so Meyka flags earnings recovery as necessary for re-rating. This is an informational grade, not investment advice.

What are the main financial risks to watch for AKZA.AS stock?

Main risks include elevated leverage (debt-to-equity **1.36**), narrow net margins, and sensitivity to raw-material costs. A weak free cash flow or negative guidance could pressure AKZA.AS stock near-term.

What price range should investors consider for AKZA.AS stock after earnings?

Meyka AI scenarios: conservative **€50.00**, base **€56.00**, optimistic **€65.00**. These targets depend on margin recovery and guidance. Forecasts are model-based projections and not guarantees.

EU Stocks

Akzo Nobel (AKZA.AS EURONEXT) €59.24 before Q4 results: Market Closed 02 Feb 2026

ByHuzaifa Zahoor February 3, 2026February 3, 2026

Akzo Nobel shares (AKZA.AS stock) closed at €59.24 on EURONEXT on 02 Feb 2026 as investors await Q4 results due 03 Feb 2026. The price sits near the 200-day average of €58.50 and trades with a PE of 179.52 and EPS €0.33. Volume was 816,112.00 shares, above the average of 517,813.00, signalling higher attention ahead of the earnings release. We examine valuation, cash flow, sector context and Meyka AI signals to frame outcomes that could move the stock at open.